BioWorld

May 19, 1992

View Archived Issues

OSTEOTECH COMPLETES ACQUISITION

Read More

REPLIGEN-LILLY DEAL WORTH MORE THAN $14M

Read More

XYTRONYX RAISES $3.2 MILLION

Read More

PHASE I RESPONSES TO FUSION TOXIN

Read More

MONDAY STOCKS

Read More

LIPID DELIVERY FOR MENINGITIS

Read More

BIOMATRIX DEAL WITH QUEBEC GOVERNMENT

Read More